Dr. Peter E. Biglin

Dr. Brummett is a Professor at the University of Michigan where he serves as the Senior Associate Chair for Research. He has more than 200 publications, including articles in top journals such as JAMA, JAMA Surgery, Anesthesiology, and Annals of Surgery. He is the Co-Director of the Opioid Prescribing Engagement Network (OPEN) at the University of Michigan, which aims to apply a preventative approach to the opioid epidemic in the US through appropriate prescribing after surgery, dentistry, and emergency medicine. In addition, his research interests include predictors of acute and chronic post-surgical pain and failure to derive benefit for interventions for interventions and surgeries primarily performed to treat pain. Dr. Brummett is interested in the impact of a fibromyalgia-like or centralized pain phenotype on analgesic outcomes. He is the Co-PI of multiple NIH grants studying these concepts and receives funding from the Michigan Department of Health and Human Services, SAMHSA, CDC, and multiple foundations. Dr. Brummett is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Fibromyalgia, Chronic Pain, Acute Pain, Shoulder Arthroscopy, and Hip Replacement. Dr. Brummett is board certified in Anesthesiology and Pain Medicine.

Edward Dabrowski is a Physiatrist practicing medicine in Roseville, Michigan. He has been practicing medicine for over 46 years. Dr. Dabrowski is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Cerebral Palsy, Spasticity, Spastic Diplegia Infantile Type, and Moebius Syndrome. Dr. Dabrowski is board certified in American Board Of Physical Medicine And Rehabilitation. Dr. Dabrowski is currently accepting new patients.

Dr. Chiodo is co-director for U-M SCIMS and has been the clinical director of Spinal Cord Injury Medicine at the University of Michigan since 2002. He has worked on the U-M SCIMS research projects, Wellness in SCI and Predictors of Health, and Quality of Life in Persons with Ventilator Assistance after SCI. He has published several manuscripts on pain management, wellness in SCI, and is preparing several manuscripts on ventilator weaning after SCI. He has served as a co-investigator for two clinical trials of Fampridine’s efficacy after SCI: as treatments for spasticity and for restrictive lung disease.Dr. Chiodo is the primary attending physician for SCI services in the UMHS Adult Rehabilitation Unit, coordinating all clinical services. Dr. Chiodo is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Spasticity, Autonomic Dysreflexia, Paraplegia, and Spinal Stenosis. Dr. Chiodo is board certified in Pain Medicine, Physical Medicine & Rehab, Spinal Cord Injury Medicine, and Electrodiagnostic Medicine.